Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
BACKGROUND Adoptive transfer of EBV-specific T cells can restore specific immunity in immunocompromised patients with EBV-associated complications.METHODS We provide results of a personalized T cell manufacturing program evaluating donor, patient, T cell product, and outcome data. Patient-tailored c...
Main Authors: | Agnes Bonifacius, Britta Lamottke, Sabine Tischer-Zimmermann, Rebecca Schultze-Florey, Lilia Goudeva, Hans-Gert Heuft, Lubomir Arseniev, Rita Beier, Gernot Beutel, Gunnar Cario, Birgit Fröhlich, Johann Greil, Leo Hansmann, Justin Hasenkamp, Michaela Höfs, Patrick Hundsdoerfer, Edgar Jost, Kinan Kafa, Oliver Kriege, Nicolaus Kröger, Stephan Mathas, Roland Meisel, Michaela Nathrath, Mervi Putkonen, Sarina Ravens, Hans Christian Reinhardt, Elisa Sala, Martin G. Sauer, Clemens Schmitt, Roland Schroers, Nina Kristin Steckel, Ralf Ulrich Trappe, Mareike Verbeek, Daniel Wolff, Rainer Blasczyk, Britta Eiz-Vesper, Britta Maecker-Kolhoff |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-06-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI163548 |
Similar Items
-
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
by: Rebecca E. Schultze-Florey, et al.
Published: (2018-06-01) -
Comparative analysis of clinical-scale IFN-gamma positive T-cell enrichment using partially and fully integrated platforms
by: Christoph Priesner, et al.
Published: (2016-09-01) -
Adoptive T-cell Immunotherapy from third-party donors: Characterization of donors and set up of a T-cell donor registry
by: Britta eEiz-Vesper, et al.
Published: (2013-01-01) -
In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV
by: Markus Benedikt Krueger, et al.
Published: (2024-04-01) -
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab
by: Sabine Tischer-Zimmermann, et al.
Published: (2023-03-01)